vs
Side-by-side financial comparison of HCI Group, Inc. (HCI) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
HCI Group, Inc. is the larger business by last-quarter revenue ($242.9M vs $123.8M, roughly 2.0× NATURES SUNSHINE PRODUCTS INC). HCI Group, Inc. runs the higher net margin — 35.0% vs 3.3%, a 31.7% gap on every dollar of revenue. On growth, HCI Group, Inc. posted the faster year-over-year revenue change (12.2% vs 4.7%). Over the past eight quarters, HCI Group, Inc.'s revenue compounded faster (8.5% CAGR vs 5.6%).
HCI Equity Partners is a Washington, DC–based private equity firm with an additional office in Chicago, Illinois.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
HCI vs NATR — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $242.9M | $123.8M |
| Net Profit | $85.0M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | — | 4.3% |
| Net Margin | 35.0% | 3.3% |
| Revenue YoY | 12.2% | 4.7% |
| Net Profit YoY | 14.6% | 1379.4% |
| EPS (diluted) | $5.45 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $242.9M | — | ||
| Q4 25 | $246.2M | $123.8M | ||
| Q3 25 | $216.3M | $128.3M | ||
| Q2 25 | $221.9M | $114.8M | ||
| Q1 25 | $216.4M | $113.2M | ||
| Q4 24 | $161.9M | $118.2M | ||
| Q3 24 | $175.3M | $114.6M | ||
| Q2 24 | $206.2M | $110.6M |
| Q1 26 | $85.0M | — | ||
| Q4 25 | $97.7M | $4.1M | ||
| Q3 25 | $65.5M | $5.3M | ||
| Q2 25 | $66.2M | $5.3M | ||
| Q1 25 | $69.7M | $4.7M | ||
| Q4 24 | $2.6M | $-321.0K | ||
| Q3 24 | $5.7M | $4.3M | ||
| Q2 24 | $54.1M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% |
| Q1 26 | — | — | ||
| Q4 25 | 58.5% | 4.3% | ||
| Q3 25 | 41.9% | 7.0% | ||
| Q2 25 | 42.5% | 3.7% | ||
| Q1 25 | 46.4% | 5.4% | ||
| Q4 24 | 3.6% | 3.8% | ||
| Q3 24 | 8.0% | 4.6% | ||
| Q2 24 | 36.9% | 5.1% |
| Q1 26 | 35.0% | — | ||
| Q4 25 | 39.7% | 3.3% | ||
| Q3 25 | 30.3% | 4.2% | ||
| Q2 25 | 29.8% | 4.6% | ||
| Q1 25 | 32.2% | 4.2% | ||
| Q4 24 | 1.6% | -0.3% | ||
| Q3 24 | 3.2% | 3.8% | ||
| Q2 24 | 26.2% | 1.2% |
| Q1 26 | $5.45 | — | ||
| Q4 25 | $7.29 | $0.23 | ||
| Q3 25 | $4.90 | $0.30 | ||
| Q2 25 | $5.18 | $0.28 | ||
| Q1 25 | $5.35 | $0.25 | ||
| Q4 24 | $0.32 | $-0.02 | ||
| Q3 24 | $0.52 | $0.23 | ||
| Q2 24 | $4.24 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $93.9M |
| Total DebtLower is stronger | $31.7M | — |
| Stockholders' EquityBook value | $1.1B | $161.6M |
| Total Assets | $2.6B | $261.1M |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $93.9M | ||
| Q3 25 | $987.9M | $95.6M | ||
| Q2 25 | $947.2M | $81.3M | ||
| Q1 25 | $754.5M | $86.5M | ||
| Q4 24 | $532.5M | $84.7M | ||
| Q3 24 | $518.8M | $78.7M | ||
| Q2 24 | $445.8M | $68.7M |
| Q1 26 | $31.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.0B | $161.6M | ||
| Q3 25 | $821.8M | $166.7M | ||
| Q2 25 | $758.6M | $163.7M | ||
| Q1 25 | $522.7M | $167.1M | ||
| Q4 24 | $453.3M | $161.0M | ||
| Q3 24 | $455.3M | $162.6M | ||
| Q2 24 | $447.3M | $156.4M |
| Q1 26 | $2.6B | — | ||
| Q4 25 | $2.5B | $261.1M | ||
| Q3 25 | $2.3B | $264.8M | ||
| Q2 25 | $2.4B | $254.9M | ||
| Q1 25 | $2.3B | $252.7M | ||
| Q4 24 | $2.2B | $240.9M | ||
| Q3 24 | $2.0B | $245.3M | ||
| Q2 24 | $1.9B | $235.8M |
| Q1 26 | 0.03× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $9.9M |
| Free Cash FlowOCF − Capex | — | $7.6M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | — | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $444.4M | $9.9M | ||
| Q3 25 | $26.7M | $18.5M | ||
| Q2 25 | $145.0M | $4.3M | ||
| Q1 25 | $162.0M | $2.6M | ||
| Q4 24 | $331.8M | $12.2M | ||
| Q3 24 | $104.1M | $9.6M | ||
| Q2 24 | $-29.0M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | $440.8M | $7.6M | ||
| Q3 25 | $25.9M | $16.8M | ||
| Q2 25 | $144.5M | $3.0M | ||
| Q1 25 | $160.3M | $1.5M | ||
| Q4 24 | $327.8M | $10.0M | ||
| Q3 24 | $103.2M | $7.9M | ||
| Q2 24 | $-30.1M | $-2.0M |
| Q1 26 | — | — | ||
| Q4 25 | 179.0% | 6.1% | ||
| Q3 25 | 12.0% | 13.1% | ||
| Q2 25 | 65.1% | 2.6% | ||
| Q1 25 | 74.1% | 1.3% | ||
| Q4 24 | 202.5% | 8.5% | ||
| Q3 24 | 58.9% | 6.9% | ||
| Q2 24 | -14.6% | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.5% | 1.9% | ||
| Q3 25 | 0.4% | 1.3% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.8% | 1.0% | ||
| Q4 24 | 2.5% | 1.9% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.5% | 3.0% |
| Q1 26 | — | — | ||
| Q4 25 | 4.55× | 2.41× | ||
| Q3 25 | 0.41× | 3.46× | ||
| Q2 25 | 2.19× | 0.81× | ||
| Q1 25 | 2.32× | 0.55× | ||
| Q4 24 | 128.41× | — | ||
| Q3 24 | 18.33× | 2.21× | ||
| Q2 24 | -0.54× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCI
Segment breakdown not available.
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
